Back to Journals » Breast Cancer: Targets and Therapy » Volume 10 » default

Breast Cancer: Targets and Therapy

ISSN: 1179-1314


Archive: Volume 10, 2018

Palliative care: needs of advanced breast cancer patients

Cherny NI, Paluch-Shimon S, Berner-Wygoda Y

Breast Cancer: Targets and Therapy 2018, 10:231-243

Published Date: 3 December 2018

Artificial intelligence methods for the diagnosis of breast cancer by image processing: a review

Sadoughi F, Kazemy Z, Hamedan F, Owji L, Rahmanikatigari M, Talebi Azadboni T

Breast Cancer: Targets and Therapy 2018, 10:219-230

Published Date: 30 November 2018

Role of curcumin in regulating p53 in breast cancer: an overview of the mechanism of action

Talib WH, Al-hadid SA, Wild Ali MB, AL-Yasari IH, Abd Ali MR

Breast Cancer: Targets and Therapy 2018, 10:207-217

Published Date: 29 November 2018

Protein expression profile and microRNA expression signature in estrogen receptor-positive and -negative breast cancers: report of two cases

Tsunoda Y, Sasaki A, Sakamoto N, Teraoka K, Nakagawa R, Koshida Y, Fukuma E

Breast Cancer: Targets and Therapy 2018, 10:195-199

Published Date: 23 November 2018

Potential clinically useful prognostic biomarkers in triple-negative breast cancer: preliminary results of a retrospective analysis

Ilie SM, Bacinschi XE, Botnariuc I, Anghel RM

Breast Cancer: Targets and Therapy 2018, 10:177-194

Published Date: 23 November 2018

Expression of chemerin correlates with a poor prognosis in female breast cancer patients

El-Sagheer G, Gayyed M, Ahmad A, Abd El-Fatah A, Mohamed M

Breast Cancer: Targets and Therapy 2018, 10:169-176

Published Date: 23 October 2018

Intracellular aggregated TRPV1 is associated with lower survival in breast cancer patients

Lozano C, Córdova C, Marchant I, Zúñiga R, Ochova P, Ramírez-Barrantes R, González-Arriagada WA, Rodriguez B, Olivero P

Breast Cancer: Targets and Therapy 2018, 10:161-168

Published Date: 15 October 2018

Psychological symptoms in adult Saudi Arabian cancer patients: prevalence and association with self-rated oral health

Ahmed AE, Albalawi AN, Qureshey ET, Qureshey AT, Yenugadhati N, AL-Jahdali H, Jazieh AR

Breast Cancer: Targets and Therapy 2018, 10:153-159

Published Date: 3 October 2018

Hypofractionated radiotherapy after conservative surgery may increase low–intermediate grade late fibrosis in breast cancer patients

Digesù C, Deodato F, Macchia G, Cilla S, Pieri M, Zamagni A, Farioli A, Buwenge M, Ferrandina G, Morganti AG

Breast Cancer: Targets and Therapy 2018, 10:143-151

Published Date: 3 October 2018

Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer

Franco YL, Vaidya TR, Ait-Oudhia S

Breast Cancer: Targets and Therapy 2018, 10:131-141

Published Date: 11 September 2018

Single-day HER2neu amplification assessment using chip-based digital PCR in formalin-fixed paraffin-embedded breast carcinoma tissue

Shah PS, Murarka S, Joshi A, Mehta B, Parmar V, Shah N, Patel K, Sands J

Breast Cancer: Targets and Therapy 2018, 10:121-129

Published Date: 23 July 2018

Complexes formed by mutant p53 and their roles in breast cancer

Bellazzo A, Sicari D, Valentino E, Del Sal G, Collavin L

Breast Cancer: Targets and Therapy 2018, 10:101-112

Published Date: 18 June 2018

Impact of semaphorin expression on prognostic characteristics in breast cancer

Butti R, Kumar TVS, Nimma R, Kundu GC

Breast Cancer: Targets and Therapy 2018, 10:79-88

Published Date: 31 May 2018

Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2– metastatic breast cancer

Forsythe A, Chandiwana D, Barth J, Thabane M, Baeck J, Tremblay G

Breast Cancer: Targets and Therapy 2018, 10:69-78

Published Date: 4 May 2018

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]

Criscitiello C, Viale G, Curigliano G, Goldhirsch A

Breast Cancer: Targets and Therapy 2018, 10:51-52

Published Date: 16 March 2018

Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer

Venturelli M, Guaitoli G, Omarini C, Moscetti L

Breast Cancer: Targets and Therapy 2018, 10:39-49

Published Date: 6 March 2018

Choosing wisely after publication of level I evidence in breast cancer radiotherapy

Niska JR, Keole SR, Pockaj BA, Halyard MY, Patel SH, Northfelt DW, Gray RJ, Wasif N, Vargas CE, Wong WW

Breast Cancer: Targets and Therapy 2018, 10:31-37

Published Date: 9 February 2018

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date

Criscitiello C, Viale G, Curigliano G, Goldhirsch A

Breast Cancer: Targets and Therapy 2018, 10:23-29

Published Date: 30 January 2018

The effects of black cohosh on the regulation of estrogen receptor (ERα) and progesterone receptor (PR) in breast cancer cells

Szmyd M, Lloyd V, Hallman K, Aleck K, Mladenovik V, McKee C, Morse M, Bedgood T, Dinda S

Breast Cancer: Targets and Therapy 2018, 10:1-11

Published Date: 18 January 2018